![](https://investorshub.advfn.com/uicon/90630.png?cb=1483725876)
Thursday, October 22, 2009 12:45:42 AM
IMO... we have a few days to trend around here, then gradual rise in PPS in anticipation of upcoming event in the 4th quarter;
PDMI time is now in the 4th Quarter of 2009. PDMI could be a significant buyout target for big Pharma (Alcon or Bausch & Lomb). Key Forward Looking Events for PDMI are;
1) They have Multiple ophthalmic products,
2) 1 pending FDA decision per 10Q (Sales of surgical products are at a standstill pending FDA approval of the Photon TM laser system),
3) CPT-11 code for reimbursement (“ The Blood Flow Analyzer™ is expected to have a new CPT reimbursement code for Medicare insurance providers issued before the end of 2009”).
4) A big boon for the company is that Paradigm Medical has announced plans to Release Its New Corneal Topographer, the Paravue, in the United States Market! That will occur in the 4th quarter.
Need more time... I wish the markets were open 24 hours a day....
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM